Lpez-Verdn S, Soto-Avila JJ, Zamora-Perez AL, Lazalde-Ramos BP, Martnez-Fierro ML, Gonzlez-Gonzlez R, Molina-Frechero  N, Isiordia-Espinoza MA, Bologna-Molina R. Patients with advanced oral squamous cell carcinoma have high levels of soluble E-cadherin in the saliva. Med Oral Patol Oral Cir Bucal. 2017 Nov 1;22 (6):e694-701. 

 

 

doi:10.4317/medoral.21907

http://dx.doi.org/doi:10.4317/medoral.21907

 

 

1. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991;251:1451-5.
https://doi.org/10.1126/science.2006419

 

2. Hanahan D and Weinberg RA. Hallmarks of Cancer: The Next Generation. Cell. 2011;144:646-74.
https://doi.org/10.1016/j.cell.2011.02.013

 

3. Sakaki T, Tamura I, Kadota H, Kakudo K. Changing expression of E- and P-cadherin during rat tongue carcinogenesis induced by 4-nitroquinoline1-oxide. J Oral Pathol Med. 2003;32:530-7.
https://doi.org/10.1034/j.1600-0714.2003.00174.x

 

4. Lewis JE, Jensen PJ, Johnson KR, Wheelock MJ. E-cadherin mediates adherens junction organization through protein kinase C. J Cell Sci. 1995;107:3615-21.

 

5. Knudsen KA, Soler AP, Johnson KP, Wheelock MJ. Interactions of alpha-actin with the cadherin catenin cellcell adhesion complex via a-catenin. J Cell Biol. 1995;130:67-77.
https://doi.org/10.1083/jcb.130.1.67

 

6. Larue L, Antos C, Butz S, Huber O, Delmas V, Dominis M, et al. A role for cadherins in tissue formation. Development. 1996;122:3185-94.

 

7. Rosado P, Leuqerica-Fernndez P, Fernndez S, Allonca E, Villallan L, de Vicente JC. E-cadherin and β-catenin expression in well-differentiated and moderately differentiated oral squamous cell carcinoma: relation with clinical variables. Br J Oral Maxillofacial Surg. 2013;51:149-56.
https://doi.org/10.1016/j.bjoms.2012.03.018

 

8. Lai-Kiu L, Xiao-Yun J, Xiang-Xiang Z, Dong-Miao W, Xiao-Ling S, Hong-Bing J. Upregulation of vimentin and aberrant expression of E-cadherin/β-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome. Mod Pathol. 2010;23:213-24.
https://doi.org/10.1038/modpathol.2009.160

 

9. Sridevi U, Jain A, Nagalaxmi V, Kumar UV, Goyal S. Expression of E-cadherin in normal oral mucosa, in oral precancerous lesions and in oral carcinomas. Eur J Dent. 2015;9:364-72.
https://doi.org/10.4103/1305-7456.163238

 

10. Pectasides E, Rampias T, Sasaki C, Perisanidis C, Kouloulias V, Burtness B, et al. Markers of Epithelial to Mesenchymal Transition in Association with Survival in Head and Neck Squamous Cell Carcinoma (HNSCC). PLOS One 2014;9:e94273.
https://doi.org/10.1371/journal.pone.0094273

 

11. David JM and Rajasekaran AK. Dishonorable Discharge: The oncogenic roles of cleaved E-cadherin fragments. Cancer Res 2012;72:1-7.
https://doi.org/10.1158/0008-5472.CAN-11-3498

 

12. Katayama M, Hirai S, Kamihagi K, Nakawa K, Yasumoto M, Kato I. Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer 1994;69:580-5.
https://doi.org/10.1038/bjc.1994.106

 

13. Tsaur I, Thurn K, Juengel E, Gust KM, Borgmann H, Mager R. sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients. J Exp Clin Res 2015;34:43.
https://doi.org/10.1186/s13046-015-0161-6

 

14. Chan AOO, Lam SK, Chu KM, Lam CM, Kwok E, Leung SY, et al. Soluble E-cadherin is a valid prognostic marker in gastric carcinoma. Gut 2001;48:808-11.
https://doi.org/10.1136/gut.48.6.808

 

15. Wong DT. Towards a simple, saliva-based test for the detection of oral cancer 'oral fluid (saliva), which is the mirror of the body, is a perfect medium to be explored for health and disease surveillance'. Expert Rev Mol Diagn 2006;6:267-72.
https://doi.org/10.1586/14737159.6.3.267

 

16. AJCC: Lip and Oral cavity. En: Edge SB, Byrd DR, Compton CC, et al., 7th eds. En: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer, 2010, pp 29-40.

 

17. National Cancer Institute available in https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-cancer-institute-nci accessed August 19, 2016.

 

18. Barnes L, Eveson JW, Reichert P, et al. World Health Organization classification of tumors. Lyon: IARC Press, 2005.

 

19. Wong DT. Salivary Diagnostics: Amazing as it might seem, doctor can detect and monitor diseases using molecules found in a sample of spit. Am Sci. 2008;96:37-43.
https://doi.org/10.1511/2008.69.3669

 

20. Arafah M, Kfoury HK, Zaidi SN. HER2/neu Immunostaining in invasive Breast Cancer: Analysis of False Positive Factors. Oman Med J. 2010;25:261-3.
https://doi.org/10.5001/omj.2010.78

 

21. Al Kassam C, Alvarez-Marcos C, Blanco I, de Los Troyos JR, Llorente JL. Diagnostic value of E-cadherin, MMP-9, activated MMP-13 and anti-p53 antibodies in squamous cell carcinomas of head and neck. Med Clin (Barc). 2007;29:761-5.
https://doi.org/10.1157/13113764

 

22. Zimmermann BG, Park NJ, Wong DT. Genomic targets in saliva. Ann N Y Acad Sci. 2007;1098:184-91.
https://doi.org/10.1196/annals.1384.002

 

23. Vered M, Allon I, Buchner A, Dayan D. E-cadherin in oral SCC: An analysis of the confounding literature and new insights related to its immunohistochemical expression. Histol Histopathol. 2012;27:141-50.

 

24. Wang C, Liu X, Chen Z, Huang H, Jin Y, Kolokythas A, et al. Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma. Mol Carcinog. 2013;52:229-36.
https://doi.org/10.1002/mc.21848

 

25. Jiang Y, Liao L, Shrestha C, Ji S, Chen Y, Peng J et al. Reduced expression of E-cadherin and p120-catenin and elevated expression of PLC- γ1 and PIKE are associated with aggressiveness of oral squamoous cell carcinoma. Int J Clin Exp Pathol. 2015;8:9042-51.

 

26. Tanaka N, Odajma T, Ogi K, Ikeda T, Satoh M. Expression of E-cadherin, α-catenin and β-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. B J of Cancer. 2003;89:557-63.
https://doi.org/10.1038/sj.bjc.6601124

 

27. Diniz-Freitas M, Garca-Caballero T, Antnez-Lpez J, Gndara-Rey JM, Garca-Garca A. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. Oral Oncol. 2006;42:190-200.
https://doi.org/10.1016/j.oraloncology.2005.07.010